These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1015636)

  • 1. [Pharmacokinetics of dextran].
    Gruber UF
    Anesth Analg (Paris); 1976; 3(4):505-8. PubMed ID: 1015636
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of dextran on coagulation and hemostasis phenomena].
    Bergentz SE
    Anesth Analg (Paris); 1976; 3(4):573-6. PubMed ID: 1015643
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of Pluronic F-68, low molecular weight dextran, mannitol, and saline as priming agents in the heart-lung apparatus. I. Pluronic F-68: first use as a plasma substitute.
    Hymes AC; Safavian MH; Arbulu A; Baute P
    J Thorac Cardiovasc Surg; 1968 Jul; 56(1):16-22. PubMed ID: 5663128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of blood constituents on brain function during perfusion experiments with the cat brain. I. Brain perfusion with artificial blood containing low molecular weight dextran].
    Morimitsu J
    Seishin Shinkeigaku Zasshi; 1968 Apr; 70(4):330-40. PubMed ID: 5693993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dextran on blood typing and cross-matching (author's transl)].
    Takenaka M; Kawai T
    Rinsho Byori; 1974 Aug; 22(Suppl):247-54. PubMed ID: 4473611
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited.
    Alexander B
    Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of hydroxyethyl starch and dextran with plasma proteins and erythrocyte envelopes.
    Thompson WL
    Biorheology; 1966 Mar; 3(2):49-58. PubMed ID: 5959203
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of pluronic F-68, low molecular weight dextran, mannitol, and saline as priming agents in the heart-lung apparatus. II. The in vitro influence on oxygen consumption of certain fluids used as priming agents in a heart-lung bypass apparatus.
    Hymes AC; Beck K
    J Thorac Cardiovasc Surg; 1968 Jul; 56(1):23-7. PubMed ID: 5663130
    [No Abstract]   [Full Text] [Related]  

  • 9. The renal effects of acute hemodilution with hydroxyethyl starch, dextran, or saline.
    Murphy GP
    Surg Gynecol Obstet; 1965 Dec; 121(6):1325-33. PubMed ID: 5851627
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on dextran and dextran derivatives. XIV. Metal binding properties of succinyl- and phthalyl-dextrans.
    Bombardieri G; Rotilio G; Crifò C; De Marco C
    Arch Biochem Biophys; 1968 Sep; 127(1):766-9. PubMed ID: 4301571
    [No Abstract]   [Full Text] [Related]  

  • 11. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect on diuresis by various blood substitutes and plasma preparations in slightly hypovolemic man].
    Gruber UF; Grass S; Meili-Gerber E; Allgöwer M
    Helv Chir Acta; 1965 Dec; 32(6):610-5. PubMed ID: 5888192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma substitutes in acute blood loss of the rabbit].
    Janzarik H; Lasch HG
    Helv Chir Acta; 1966 May; 33(3):392-403. PubMed ID: 5994659
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of plasma substitutes on the suspension stability of human blood.
    Heeres SG; Zijlstra WG
    Bibl Haematol; 1968; 29():1167-71. PubMed ID: 5700313
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of plasma substitutes on blood viscosity and red cell agglutination].
    Takayanagi M; Oda T; Hatakeda A; Fukuchi H; Hase H
    Masui; 1971 Sep; 20(10):951-2. PubMed ID: 5166809
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of plasma viscosity changes after osmo-and oncotherapy on the hemodynamics].
    Schmidt K
    Anaesthesist; 1970 Apr; 19(4):146-52. PubMed ID: 5516559
    [No Abstract]   [Full Text] [Related]  

  • 17. The plasma volume expanding effect of low molecular weight dextran in the hypothermic dog.
    DRAKE CT; LEWIS FJ
    Surg Forum; 1961; 12():182-4. PubMed ID: 13887717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative in vitro effects of industrial macromolecules on blood coagulation factors].
    Migne J; Chanfreau JM; Dubois J; Monteil R
    Rev Fr Transfus; 1969; 12(1):Suppl:427-38. PubMed ID: 5376621
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble dextran-hemoglobin complex as a potential blood substitute.
    Tam SC; Blumenstein J; Wong JT
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2128-31. PubMed ID: 1064880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of a new plasma expander, hydroxyethyl starch. 3. Statistical comparisons between hydroxyethyl starch and dextran 70 on blood pressure, blood analysis, electrolytes and hemostasis].
    Amakata Y; Tanaka K; Hanai A; Kosaki G
    Masui; 1972 Mar; 21(3):225-32. PubMed ID: 5064134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.